Skip to content

Author

E. Shinozaki

We have 5 of 383 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Evaluation of clinical outcomes and prognostic factors in patients with metastatic appendiceal adenocarcinoma treated with first-line chemotherapy: A multi-institutional retrospective study.

Background Appendiceal adenocarcinoma (AA) is a rare cancer characterized by high incidences of mucinous histology, peritoneal metastasis, and a good prognosis. However, its chemotherapeutic efficacy and prognostic factors are unclear. Objective To evaluate real-world clinical outcomes and explore prognostic factors...

K. Fukuda, H. Osumi, A. Takashima et al. · 0 citations
Sep 2026

Prognostic Role of Pretreatment Nutritional and Inflammatory Status in Unresectable Metastatic Colorectal Cancer: Supplementary Analysis of JCOG1007.

Findings further support avoiding routine PTR, regardless of host status, as patients with impaired host status tended to have shorter overall survival and PFS after PTR than after chemotherapy alone.

Taichi Horino, K. Komori, Y. Ishikawa et al. · 1 citation
Open access Aug 2026

Proteinuria as the cause of early dose modification in Japanese patients with metastatic colorectal cancer treated with fruquintinib: a multicenter real-world study.

Fruquintinib demonstrated feasible effectiveness and manageable toxicity in Japanese patients with mCRC and proteinuria was a major determinant of treatment feasibility and frequently led to early dose modification.

Shohei Udagawa, Chihiro Ishizuka, H. Osumi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.